- Home
- RPTX vs ANVS Comparison
RPTX vs ANVS Comparison
Compare RPTX & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- ANVS
- Stock Information
- Founded
- RPTX 2016
- ANVS 2008
- Country
- RPTX Canada
- ANVS United States
- Employees
- RPTX N/A
- ANVS N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- ANVS Health Care
- Exchange
- RPTX Nasdaq
- ANVS Nasdaq
- Market Cap
- RPTX 69.2M
- ANVS 55.5M
- IPO Year
- RPTX 2020
- ANVS 2020
- Fundamental
- Price
- RPTX $1.69
- ANVS $2.29
- Analyst Decision
- RPTX Strong Buy
- ANVS Strong Buy
- Analyst Count
- RPTX 3
- ANVS 4
- Target Price
- RPTX $4.50
- ANVS $17.33
- AVG Volume (30 Days)
- RPTX 91.2K
- ANVS 231.1K
- Earning Date
- RPTX 11-06-2025
- ANVS 11-07-2025
- Dividend Yield
- RPTX N/A
- ANVS N/A
- EPS Growth
- RPTX N/A
- ANVS N/A
- EPS
- RPTX N/A
- ANVS N/A
- Revenue
- RPTX $250,000.00
- ANVS N/A
- Revenue This Year
- RPTX N/A
- ANVS N/A
- Revenue Next Year
- RPTX N/A
- ANVS N/A
- P/E Ratio
- RPTX N/A
- ANVS N/A
- Revenue Growth
- RPTX N/A
- ANVS N/A
- 52 Week Low
- RPTX $0.89
- ANVS $1.11
- 52 Week High
- RPTX $4.07
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- RPTX 66.56
- ANVS 40.26
- Support Level
- RPTX $1.66
- ANVS $2.21
- Resistance Level
- RPTX $1.60
- ANVS $2.51
- Average True Range (ATR)
- RPTX 0.06
- ANVS 0.13
- MACD
- RPTX 0.01
- ANVS -0.02
- Stochastic Oscillator
- RPTX 80.95
- ANVS 14.55
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.